SEC Form 4 · accession 0001683168-26-006553
CNS Pharmaceuticals, Inc. · CNSP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michal Fisher
Director
Period of report
May 18, 2026
Accepted (ET)
Aug 18, 2026 · 9:01 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001729427
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 18, 2026 | P | 2,000 | $5.00 | A | 2,000 | D |
Table II — derivative securities
No Table II lines on this filing.